Evidence of a post-Thanksgiving surge should be emerging this week, a Harvard epidemiologist said, advising people who gathered together to get tested or assume they’re infected.
Dec. 2, 2020 • ~5 min
covid-19 coronavirus harvard-medical-school health-medicine alvin-powell harvard-th-chan-school-of-public-health the-forum-at-harvard-th-chan-school-of-public-health vaccine thanksgiving megan-murray
Experts said the complex rollout of a coronavirus vaccine gives the U.S. a chance for a win after the virus gained the upper hand in its initial phase.
Nov. 23, 2020 • ~8 min
covid-19 coronavirus health-medicine alvin-powell harvard-th-chan-school-of-public-health the-forum-at-harvard-th-chan-school-of-public-health marc-lipsitch vaccine barry-bloom sarah-fortune pfizer moderna rochelle-walensky
Barry Bloom from the Harvard T.H. Chan School of Public Health offers context about the news that two experimental vaccines appear to confer a high level of protection from the coronavirus.
Nov. 19, 2020 • ~5 min
covid-19 health-medicine vaccine barry-bloom
A public campaign to build trust may be needed if a successful vaccine candidate is to be taken by enough Americans to interrupt the COVID pandemic, a Harvard public health expert said.
Sept. 16, 2020 • ~6 min
covid-19 coronavirus pandemic health-medicine alvin-powell the-forum-at-harvard-th-chan-school-of-public-health vaccine barry-bloom anti-vaxxers new-england-journal-of-medicine glen-nowak vaccine-skepticism walter-orenstein
BIDMC-led research team reports vaccine protection against severe COVID-19-related pneumonia and death.
Sept. 3, 2020 • ~4 min
covid-19 coronavirus health-medicine beth-israel-deaconess-medical-center vaccine dan-barouch
A biomaterials-based infection vaccine strategy shows first promise in eliciting immunity against SARS-CoV-2 and could be applied broadly to stave off infectious disease.
Aug. 19, 2020 • ~8 min
science-technology covid-19 coronavirus david-mooney wyss-institute vaccine omnivax
Vaccines that might protect against COVID-19 have entered phase 3 trials — the last step before regular approval in humans — in record time, but the virus has moved faster, experts say.
July 28, 2020 • ~8 min
harvard-medical-school health-medicine alvin-powell george-daley vaccine dan-barouch moderna bisola-ojikutu lindsey-baden massachusetts-consortium-for-pathogen-readiness masscpr nicole-frahm
Harvard economist and former Treasury Secretary Lawrence Summers said we’re in greater danger of doing too little to fight COVID-19 than too much.
June 19, 2020 • ~6 min
covid-19 coronavirus health-medicine alvin-powell harvard-th-chan-school-of-public-health michelle-williams vaccine stimulus lawrence-summers therapeutic
Harvard-affiliated Beth Israel Deaconess Medical Center has developed vaccines — currently being tested in animal models — that are designed to train the body’s immune system to recognize the virus swiftly upon exposure and respond quickly to disable it.
May 20, 2020 • ~8 min
covid-19 coronavirus harvard-medical-school health-medicine ragon-institute vaccine sars-cov-2 dan-h-barouch re-infection
Rising nationalism and global inequity will be hurdles to the distribution of COVID vaccines, despite the comparatively “lightning” fast scientific response to the pandemic so far, a Harvard infectious disease expert said Thursday.
May 8, 2020 • ~8 min
covid-19 health-medicine alvin-powell harvard-th-chan-school-of-public-health yonatan-grad the-forum-at-harvard-th-chan-school-of-public-health vaccine barry-bloom